Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
14.51
+1.03 (7.64%)
At close: Apr 8, 2026, 4:00 PM EDT
14.63
+0.12 (0.83%)
After-hours: Apr 8, 2026, 7:44 PM EDT

Relay Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,5931,4716911,4031,8093,323
Market Cap Growth
399.93%112.82%-50.75%-22.44%-45.55%-11.06%
Enterprise Value
2,071945.11-47.39701.78863.972,386
Last Close Price
14.518.464.1211.0114.9430.71
PE Ratio
--5.25-1.75-3.95-5.77-8.04
PS Ratio
168.8995.7969.0754.931310.221097.11
PB Ratio
4.452.590.891.871.903.70
P/TBV Ratio
4.392.560.761.801.773.25
P/FCF Ratio
--6.24-2.75-4.61-7.58-42.67
P/OCF Ratio
--6.25-2.77-4.67-7.88-44.66
EV/Sales Ratio
134.8961.55-4.7427.47625.61787.76
EV/EBITDA Ratio
--3.160.13-1.91-2.93-6.61
EV/EBIT Ratio
--3.120.13-1.88-2.89-6.54
EV/FCF Ratio
--4.010.19-2.31-3.62-30.64
Debt / Equity Ratio
0.050.050.050.060.060.02
Debt / EBITDA Ratio
-0.11-0.11-0.13-0.14-0.20-0.06
Debt / FCF Ratio
-0.14-0.14-0.19-0.18-0.24-0.29
Net Debt / Equity Ratio
-0.92-0.92-0.94-0.93-0.99-1.04
Net Debt / EBITDA Ratio
1.751.752.001.893.192.59
Net Debt / FCF Ratio
2.212.212.922.293.9512.01
Asset Turnover
0.020.020.010.030.000.00
Quick Ratio
21.6821.6815.4024.7815.6839.41
Current Ratio
22.6122.6115.9525.4416.0040.14
Return on Equity (ROE)
-41.12%-41.12%-44.15%-40.18%-31.44%-43.81%
Return on Assets (ROA)
-40.56%-40.56%-43.43%-38.38%-28.39%-40.34%
Return on Invested Capital (ROIC)
-604.85%-604.85%-598.66%-543.07%-622.78%-527.81%
Return on Capital Employed (ROCE)
-42.75%-42.75%-45.58%-40.33%-29.63%-41.20%
Earnings Yield
-10.66%-19.03%-57.28%-25.34%-17.34%-12.44%
FCF Yield
-9.10%-16.04%-36.33%-21.69%-13.18%-2.34%
Buyback Yield / Dilution
-20.10%-20.10%-16.55%-9.22%-17.97%-123.22%
Total Shareholder Return
-20.10%-20.10%-16.55%-9.22%-17.97%-123.22%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q